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Objective: Peroxiredoxins (Prxs) play an important role in regulating cellular differentiation and proliferation in several types of mammalian 
cells. This report examined the expression of Prx isotype I in the rat ovary after hormone treatment. 
Methods: Immature rats were injected with 10 IU of pregnant mare’s serum gonadotropin (PMSG) to induce the growth of multiple preovula-
tory follicles and 10 IU of human chorionic gonadotropin (hCG) to induce ovulation. Immature rats were also treated with diethylstilbestrol 
(DES), an estrogen analogue, to induce the growth of multiple immature follicles. Northern blot analysis was performed to detect gene expres-
sion. Cell-type specific localization of Prx I mRNA were detected by in situ hybridization analysis. 
Results: During follicle development, ovarian Prx I gene expression was detected in 3-day-old rats and had increased in 21-day-old rats. The 
levels of Prx I mRNA slightly declined one to two days following treatment with DES. A gradual increase in Prx I gene expression was observed 
in ovaries obtained from PMSG-treated immature rats. Furthermore, hCG treatment of PMSG-primed rats resulted in a gradual stimulation of 
Prx I mRNA levels by 24 hours (2.1-fold increase) following treatment, which remained high until 72 hours following treatment. In situ hybrid-
ization analysis revealed the expression of the Prx I gene in the granulosa cells of PMSG-primed ovaries and in the corpora lutea of ovaries stim-
ulated with hCG for 72 hours. 
Conclusion: These results demonstrate the gonadotropin and granulosa cell-specific stimulation of Prx I gene expression, suggesting its role as 
a local regulator of follicle development.
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Introduction
Peroxiredoxins (Prxs) have recently been the subject of growing in-
terest as a new family of thiol-specific antioxidant proteins [1]. These 
agents have been shown to play a critical role in peroxide detoxifica-
tion by using reducing equivalents provided through the thioredoxin 
system but not from glutaredoxin [2,3]. They exist in multiple isoforms 
[4,5] and catalyze the reduction of a broad range of different perox-
ides, including H2O2, alkyl hydroperoxides and peroxynitrite. The exis-
tence of different members of the Prx family has already been ob-
served in a variety of organisms, ranging from archaea to mammals [6]. 
The mammalian peroxiredoxin family consists of six proteins (Prx 
I-VI) expressed as unique gene products, with the capability of reduc-
ing hydrogen peroxide, lipid hydroperoxides, and peroxynitrite [7-10]. 
Prx I-IV are categorized as typical 2-Cys peroxiredoxins, distinct from 
the atypical 2-Cys (Prx V) and 1-Cys peroxiredoxin (Prx VI). Prx I-IV are 
members of a family containing a cysteine (Cys) on both the N- and 
C-terminal and form a homodimer with a head-to-tail type associa-
tion [2]. Prx V, a monomeric form, also contains two Cys; this protein 
is the most recently discovered Prx from a mammalian system [11]. 
Prx V is known to regulate apoptosis by inhibiting the p53-induced 
reactive oxygen species (ROS) formation [12]. Prx VI (1-Cys) contains 
only one Cys residue in the catalytic site and functions as a monomer 
[2]. Among these Prxs, Prx I is a basic (pH 8.3) 22-kDa protein local-
ized to the cytosol. Prx I is upregulated in a variety of cell types fol-
lowing exposure to oxidative stress. Upregulation of Prx I in response 
to H2O2 was first demonstrated in mouse peritoneal macrophages 
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[13] and in cultured vascular smooth muscle cells following exposure 
to oxidized low-density lipoprotein [14].
In the ovary, regression of the corpus luteum is an example of de-
generation of cellular function. Luteinizing hormone (LH) causes de-
pletion of ascorbic acid in the corpus luteum. Furthermore, reactive 
oxygen species have been shown to play a role in the regression of 
the corpus luteum [15]. However, the expression of Prx I in the ovary 
has not been reported. In the present study, therefore, the expression 
of Prx I was examined in the rat ovary.
Methods
1. Animals
Immature female rats of the Sprague-Dawley strain were purchased 
from Daehan Laboratories (Eumsung, Korea). They were housed in 
groups in a room with a controlled temperature and photoperiod 
(10-hours dark, 14-hours light, with lights on from 0600-2000 hours). 
The animals had access to food and water ad libitum. The animals, 
ranging in age from 3-21 days, were killed by cervical dislocation, and 
the ovaries were removed for RNA analysis. Ovaries were also collect-
ed from immature (26-day-old) rats at various times after treatment 
with 10 IU pregnant mare’s serum gonadotropin (PMSG) (Sigma Che-
mical Co., St. Louis, MO, USA) to induce multiple follicle growth. To 
obtain immature growing granulosa cells for the proliferation assay, 
rats were treated with diethylstilbestrol (DES) (Sigma Chemical Co.) 
at 22 days of age. Some rats received a single intraperitoneal injec-
tion of 10 IU human chorionic gonadotropin (hCG) (Sigma Chemical 
Co.) to induce ovulation, and ovaries were obtained at different time 
intervals for northern blot and in situ hybridization analysis. Three to 
four ovarian samples obtained from different animals were included 
in the analysis. All animal handling and procedures were approved 
by the Institutional Animal Care and Use Committee of Chonnam 
National University. 
2. PCR cloning of rat Prx I
Total RNA from the rat brain, testis, and lung was isolated using Tri-
reagent solution. Five micrograms of total RNA were reverse tran-
scribed using the Superscript Preamplification System (Gibco, Gaith-
ersburg, MD, USA) according to the instruction manual. One micro-
gram of reverse transcribed cDNA and 100 pM of primer (Prx I’s anti-
sense, 5’-GAG TTT CTT AAA TTC TTC TGC TCT A-3’ and sense, 5’-CTT 
CAG GAA ATG CAA AAA TTG GGC AT-3’) was added in a final volume 
of 100 µL containing 250 µM each deoxynucleotide triphosphates, 2 
mM MgCl2, and 0.2 U Taq polymerase. PCR was performed for 30 cy-
cles with denaturing at 94°C for 1 minute, annealing at 65°C for 1.5 
minutes, and elongation at 72°C for 1 minute. PCR products of the 
expected size (Prx I; 203 bp) were subcloned into pGEM-T Easy Vector 
(Promega Co., Madison, WI, USA), and sequenced using T7 and T3 
primers with automatic DNA sequencer (Perkin-Elmer, Foster City, 
CA, USA).
3. Northern blot analysis
Total RNA from ovaries was isolated using Tri-reagent solution (Mo-
lecular Research Center Inc., Cincinnati, OH, USA). Twenty micrograms 
of total RNA were fractionated by electrophoresis on a 1% agarose 
gel containing formaldehyde, and transferred to nylon membranes 
by capillary blotting with 10×sodium citrate-sodium chloride (SSC). 
After UV cross-linking and prehybridization, membranes were hy-
bridized overnight at 42°C in solution containing 50% formaldehyde, 
5×SSC, 1 mM EDTA, 250 µg/mL denatured salmon sperm DNA, and 
a total of 2-4×10
6 cpm of α
32P-labeled rat Prx I cDNA probes. After 
hybridization, membranes were washed twice for 5 minutes at room 
temperature in 2×SSC and 0.1% SDS, followed by 1 hour at 65°C in 
0.5×SSC and 0.1% SDS. Membranes were then exposed using Kodak 
RX films (Eastman Kodak Co., Rochester, NY, USA) for 1-4 days at -80°C.
4. In situ hybridization analysis
Rat ovaries were fixed at 4°C for 6 hours in 4% paraformaldehyde in 
phosphate-buffered saline (PBS), followed by immersion in 0.5 M su-
crose in PBS overnight. Cryostat sections (14 µm thick) were mount-
ed on poly-L-lysine (Sigma Chemical Co.) coated microscope slides, 
fixed in 4% paraformaldehyde in PBS, and stored at -70°C until ana-
lyzed. The hybridization procedure was essentially the same as previ-
ously described [16]. In brief, sections were pretreated serially with 
0.2 M HCl, 2×SSC, pronase E (0.125 mg/mL), 4% paraformaldehyde, 
and acetic anhydride in triethanolamine. Hybridization was carried 
out at 52-55°C overnight in the mixture containing 
35S-labeled rat Prx 
I cRNA probe (10
8 cpm/mL), 50% formamide, 0.3 M NaCl, 10 mM Tris-
HCl, 5 mM EDTA, 1×Denhardt’s solution, 10% dextran sulfate, 1 mg/
mL carrier transfer RNA, and 10 mM dithiothreitol. Post-hybridization 
washing was performed under stringent conditions that included ri-
bonuclease A (25 mg/mL) treatment at 37°C for 30 minutes and a fi-
nal stringency of 0.1×SSC. Slides were dipped into NTB-2 emulsion 
(Eastman Kodak Co.) and exposed at 4°C until being developed after 
3 weeks. The slides were stained with hematoxylin and eosin and ex-
amined under a light microscope with bright- and dark-field illumi-
nation.
5. Data analysis
Statistical analyses of data in graphs were carried out by one-way 
ANOVA followed by Dunnett’s test. A Student’s t-test was performed 
to compare the two groups. A value of p<0.05 was considered sig-
nificant.   doi: 10.5653/cerm.2011.38.1.18
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Results
1. Levels of Prx I mRNAs during development
The developmental changes in Prx I mRNA levels in the ovary were 
determined by a northern blot analysis. As shown in Figure 1A, the 
levels of 0.8 Kb Prx I transcripts were increased during development. 
The levels of ovarian Prx I transcript were three times higher in 21-day-
old rats and two times higher in 15-day-old rats than those in 3-day-
old or 6-day-old rats (p<0.05) (Figure 1B).  
2. Regulation of Prx I expression by estrogen
To study the effect of estrogen on Prx I expression in vivo, total RNA 
extracted from ovaries at different days after implantation of capsules 
containing diethylstilbestrol (DES) was analyzed by northern blotting. 
The levels of Prx I mRNA slightly, but not significantly, declined 1-2 
days after DES treatment (Figure 2).
3. Gonadotropin regulation of Prx I mRNA levels
To examine gonadotropin regulation of Prx I mRNA levels in the 
ovary, total RNA extracted from ovaries at different times after go-
nadotropin treatments was analyzed by northern blotting. As shown 
in Figure 3A, PMSG treatment of 26-day-old immature rats caused an 
increase in ovarian expression of the Prx I gene. Prx I expression was 
markedly increased in ovaries treated with PMSG for 48 hours (two-
fold increase; p<0.05) (Figure 3B). The hypothalamus used as a posi-
tive control also expressed the Prx I gene. Furthermore, treatment 
with hCG of PMSG-primed rats resulted in the stimulation of Prx I 
mRNAs within 24 hours (p<0.05) (Figure 4A). High levels remained 
until 72 hours post-hCG treatment, which corresponds to the period 
Figure 1. Developmental expression of Peroxiredoxin (Prx) I mRNAs 
in immature rat ovaries. (A) Aliquots of total RNA (20 μg) isolated from 
ovaries on the indicated postnatal days were assayed for Prx mRNA 
levels by northern blotting using a rat Prx cDNA probe. The estimated 
size (0.8 kb) of the Prx I transcript is indicated. The expression of 28 S 
ribosomal RNA was used as an internal standard. (B) Quantitative es-
timation of ovarian Prx I mRNA levels during development. The 0.8 
kb Prx I transcript was quantified using a phosphorimager and nor-
malized for 28 S ribosomal RNA levels in each sample. Results are ex-
pressed relative to ovarian Prx I mRNA levels found at 3 days of age. 
Each data point represents the mean±SE from four independently 
performed experiments. 
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Figure 2. Expression of Prx I mRNA in ovaries of diethylstilbestrol 
(DES)-treated immature rats. (A) Ovarian total RNA was extracted at 
the indicated time interval after DES implantation. Aliquots of total 
RNA (20 μv) isolated from ovaries on the indicated postnatal days 
were assayed for Peroxiredoxin (Prx) I mRNA levels by northern blot-
ting using a rat Prx cDNA probe. The estimated size (0.8 kb) of the Prx 
I transcript is indicated. The expression of 28 S ribosomal RNA was 
used as an internal standard. (B) Quantitative estimation of ovarian 
Prx I mRNA levels during development. The 0.8 kb Prx I transcript was 
quantified using a phosphorimager and normalized for 28 S ribosom-
al RNA levels in each sample. Results are expressed relative to ovarian 
Prx I mRNA levels found at 0 days of age. Each data point represents 
the mean±SE from four independently performed experiments. 
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Figure 3. Changes in Peroxiredoxin (Prx) I mRNA levels in ovaries of 
pregnant mare’s serum gonadotropin (PMSG)-treated immature rats. 
(A) Aliquots of total RNA (20 µA) isolated from ovaries at the indicat-
ed time intervals after PMSG stimulation were assayed for Prx I mRNA 
levels by northern blotting using a rat Prx cDNA probe. The estimated 
size (0.8 kb) of the Prx transcript is indicated. The expression of 28 S 
ribosomal RNA was used as an internal standard. Hy po, hypothala-
mus. (B) Quantitative estimation of ovarian Prx mRNA levels during 
gonadotropin stimulation. The 0.8 kb Prx I transcript was quantified 
using a phosphorimager and normalized for 28 S ribosomal RNA lev-
els in each sample. Results are expressed relative to the ovarian Prx I 
mRNA levels found at 0 hour after PMSG treatment for PMSG-treated 
rat ovaries. Each data point represents the mean±SE from three to 
four independently performed experiments. 
ap<0.05 vs. PMSG 0 hour.
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of corpus luteum formation (Figure 4B). The levels of Prx I mRNA 
slightly declined 9-12 hours after stimulation. 
4. Localization of Prx I mRNAs in the rat ovary
To determine the cell types expressing Prx I mRNA in hormone-
stimulated ovaries, antisense and sense cRNA probes for rat Prx I were 
generated for in situ hybridization analysis. In the ovaries of PMSG-
primed immature rats, Prx I transcripts were detected in granulosa 
cells of preovulatory follicles (Figure 5A, 5C). In addition, in the ova-
ries of PMSG-primed immature rats followed by hCG stimulation for 
72 hours, high levels of Prx I mRNA were expressed in corpus luteum 
cells (Figure 5B, 5D). No specific signal was detected in follicles hy-
bridized with the sense probe (Figure 5E-5H).
Discussion
The present study demonstrates that Prx I levels were regulated 
during follicle development in the rat ovary. Northern blot analysis, 
showing an increase in 0.8 kb Prx I transcription in the ovaries of 
21-day-old rat, suggests the possible role of Prx in follicle growth. 
Furthermore, the expression of Prx isotypes was stimulated by go-
nadotropins during corpus luteum formation.
Figure 4. Changes in Peroxiredoxin (Prx) I mRNA levels in 
ovaries of pregnant mare’s serum gonadotropin (PMSG)/hCG-
treated immature rats. (A) Aliquots of total RNA (20 µA) iso-
lated from ovaries at the indicated time intervals after PMSG/ 
hCG stimulation were assayed for Prx I mRNA levels by north-
ern blotting using a rat Prx cDNA probe. The estimated size 
(0.8 kb) of Prx transcript is indicated. The expression of 28 S 
ribosomal RNA was used as an internal standard. (B) Quanti-
tative estimation of ovarian Prx I mRNA levels during gona-
dotropin stimulation. The 0.8 kb Prx I transcript was quanti-
fied using a phosphorimager and normalized for 28 S ribo-
somal RNA levels in each sample. Results are expressed rela-
tive to the ovarian Prx I mRNA levels found at 0 hour after 
hCG treatment for PMSG/hCG treated rat ovaries. Each data 
point represents the mean±SE from three to four indepen-
dently performed experiments. 
ap<0.05 vs. hCG 0 hour.
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Figure 5. In situ localization of Peroxiredoxin (Prx) I mRNA in the rat ovary. Ovarian sections, obtained from immature rats treated with pregnant 
mare’s serum gonadotropin/hCG, were hybridized with 
35S-labeled rat Prx I cRNA probes. Photomicrographs were taken under bright (A, B, E, 
and F) and dark-field (C, D, G, and H) illumination. Adjacent sections, hybridized with the Prx I sense probe, showed only background signals (E, 
F, G, and H). CL, corpus luteum. *Granulosa cells of preovulatory follicles. Bar=100 μm. 
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Reactive oxygen species (ROS), the natural metabolites of intracel-
lular oxygen, are constantly created and destroyed within the cell as 
a means of maintaining strict redox homeostasis. ROS such as hydro-
gen peroxide (H2O2) and superoxide are created as a result of normal 
cellular signaling and metabolism [17], including oxidative phos-
phorylation [18]. Other causes of increased ROS levels include expo-
sure to various drugs and hormones [19] and the overexpression of 
certain oncoproteins [20]. A group of enzymes that plays a major role 
in ROS regulation is the Prx family. Prxs reduce hydrogen peroxide 
and other peroxide substrates via conserved cysteine residues utiliz-
ing thiol-containing proteins, such as glutathione or thioredoxin, as 
electron donors [2,21,22].
Intracellular ROS are a double-edged sword with both beneficial 
and deleterious consequences. On the one hand, ROS participate in 
normal cell signaling pathways [22-24]. For example, H2O2 oxidizes 
cysteine residues in protein-tyrosine phosphatases, which inhibits 
their function and leads to the upregulation of multiple tyrosine ki-
nase-dependent signaling pathways in response to growth factors 
[8,25]. The best studied means for regulating ROS levels is via the Prxs. 
Each of the six mammalian Prxs has a specific tissue and subcellular 
distribution [2,21]. The most abundant and ubiquitous member of 
the Prxs, Prx I, is expressed at high levels in virtually every tissue, pri-
marily as a nuclear ROS scavenger. Reactive oxygen species, includ-
ing the superoxide anion and hydrogen peroxide, are generated in 
the ovary, but their origin is unknown [26]. Follicles and corpora lutea 
are subject to ischemic episodes, and leukocytic infiltration is evident 
at ovulation and leuteolysis [27]. Furthermore, xanthine oxidase in 
the presence of hypoxanthine evokes marked antigonadotropic and 
antisteroidogenic actions in ovarian cells [28]. Recent evidence links 
superoxide radical production to the regulation of corpus luteum 
function in the rat. In vivo treatment with prostaglandin F2α stimu-
lates a burst of superoxide radicals shortly before progesterone se-
cretion decreases [26], and generation of these radicals appears to be 
controlled by intracellular signaling pathways [29]. Therefore, the 
present observation, showing the stimulation of Prx I expression dur-
ing corpus luteum formation, may implicate Prx in the initiation of 
corpus luteum formation by modulating superoxide radical produc-
tion, and in turn, the generated superoxide radicals may alter proges-
terone production and thereby maintain the formation of the corpus 
luteum. 
During follicle development, Prx I may play an important role in 
theca cell differentiation. It is known that ovarian follicular growth 
begins and proceeds to the late preantral stage independently of go-
nadotropin regulation [30]. Further development depends upon FSH 
acting upon its cognate receptor expressed by granulosa cells [31]. It 
has been suggested that insulin-like growth factor I, expressed in gran-
ulosa cells of healthy growing follicles, may promote follicle growth 
by augmenting granulosa cell FSH receptor responsiveness [32], and 
thereby amplifying FSH-induced aromatase expression and LH re-
ceptor induction [33]. Similarly, activin has been shown to promote 
folliculogenesis during the preantral or early antral stages of growth 
of follicles by amplifying granulosa cell responsiveness to FSH [34]. 
Because the pattern of Prx expression seems to follow the spatial ex-
pression of P450scc [35] and steroidogenic acute regulatory protein 
[36] in cells engaged in steroidogenic activity, Prx I expression in the 
theca cells may be correlated with terminal commitment of cells for 
steroidogenic differentiation.
In summary, the present study demonstrates the presence and reg-
ulation of Prx I expression in the gonadotropin-treated ovaries. Stim-
ulation of Prx I expression by gonadotropins indicates that Prx I may 
have a physiological function during ovarian follicle development. 
Particularly, the function of Prx I in corpus luteum formation remains 
to be established.
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